Recombinant TNFRSF12A (Enavatuzumab Biosimilar) antibody

Catalog No. ABIN7597658

This anti-TNFRSF12A (Enavatuzumab Biosimilar) antibody is a Humanized Chimeric antibody detecting TNFRSF12A (Enavatuzumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant TNFRSF12A (Enavatuzumab Biosimilar) antibody (ABIN7597658)

Target: TNFRSF12A (Enavatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This TNFRSF12A (Enavatuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-TNFRSF12A (Enavatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Enavatuzumab Biosimilar Antibody

Specificity: FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 3.33 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for TNFRSF12A (Enavatuzumab Biosimilar)

Target: TNFRSF12A (Enavatuzumab Biosimilar)

Alternative Name: Enavatuzumab Biosimilar

Target Type: Biosimilar

Background: FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A

UniProt: Q9NP84

CAS-No: 1062149-33-0